World Health Organization. 2021. 10 Global Health Issues to Track in 2021. https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021.

Antimicrobial Resistance Collaborators. 2022. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 399, 629–655.

Article  Google Scholar 

Manyi-Loh C., Mamphweli S., Meyer E., Okoh A. 2018. Antibiotic use in agriculture and its consequential resistance in environmental sources: Potential public health implications. Molecules. 23, 795–842.

Article  PubMed  PubMed Central  Google Scholar 

Olsufyeva E.N., Yankovskaya V.S., Dunchenko N.I. 2022. Review of the risks of antibiotic contamination in dairy products. Antibiot. Khimioter. 67 (7–8), 82–96.

Article  CAS  Google Scholar 

Mann A., Nehra K., Rana J.S., Dahiya T. 2021. Antibiotic resistance in agriculture: Perspectives on upcoming strategies to overcome upsurge in resistance. Curr. Res. Microb. Sci. 2, 100030–100043.

CAS  PubMed  PubMed Central  Google Scholar 

Painuli S., Semwal P., Sharma R., Akash S. 2023. A new threat to the society. Health Sci. Rep. 6, e1480–e1482.

Article  PubMed  PubMed Central  Google Scholar 

WHO Strategic Priorities on Antimicrobial Resistance Preserving antimicrobials for today and tomorrow. 18 May 2022. https://www.who.int/publications/i/item/ 9789240041387

Mirzaei R., Campoccia D., Ravaioli S., Arciola C.R. 2024. Emerging issues and initial insights into bacterial biofilms: From orthopedic infection to metabolomics. Antibiotics. 13, 184–206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olsufyeva E.N., Yankovskaya V.S. 2020. Main trends in the design of semi-synthetic antibiotics of a new generation. Russ. Chem. Rev. 89 (3), 339–378.

Article  CAS  Google Scholar 

Rubinstein E., Keynan Y. 2014. Vancomycin revisited—60 years later. Front. Public Health. 2, 217–223.

Article  PubMed  PubMed Central  Google Scholar 

Vimberg V. 2021. Teicoplanin—a new use for an old drug in the COVID-19 era? Pharmaceuticals. 14, 1227–1238.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goldberg L.E., Stepanova E.S., Vertogradova T.P., Shevnyuk L.A., Shepelevtseva N.G. 1987. Preclinical toxicological studies of the new antibiotic eremomycin I. Acute toxicity in laboratory animals. Antibiot. Med. Biotekhnol. 32, 910–915.

CAS  PubMed  Google Scholar 

Van Groesen E., Innocenti P., Martin N.I. 2022. Recent advances in the development of semisynthetic glycopeptide antibiotics: 2014–2022. ACS Infect. Dis. 8, 1381–1407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zamone W., Prado I.R.S., Balbi A.L., Ponce D. 2019. Vancomycin dosing, monitoring and toxicity: Critical review of the clinical practice. Clin. Exp. Pharmacol. Physiol. 46, 292–301.

Article  Google Scholar 

Li G., Walker M.J., De Oliveira D.M.P. 2023. Vancomycin resistance in Enterococcus and Staphylococcus aureus. Microorganisms. 11, 24–74.

Article  Google Scholar 

Walsh C., Wencewicz T. 2016. Antibiotics: Challenges, Mechanisms, Opportunities. Washington: ASM Press.

Book  Google Scholar 

Bugg T.D.H., Wright G.D., Dutka-Malen S., Arthur M., Courvalin P., Walsh C.T. 1991. Molecular basis of vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry. 30, 10408–10415.

Article  CAS  PubMed  Google Scholar 

Healy V.L., Lessard I.A.D., Roper D.I., Knox J.R., Walsh C.T. 2000. Vancomycin resistance in enterococci: Reprogramming of the D-Ala-D-Ala ligases in bacterial peptidoglycan biosynthesis. Chem. Biol. 7, R109–R119.

Article  CAS  PubMed  Google Scholar 

Hughes C.S., Longo E., Phillips-Jones M.K., Hussain R. 2017. Characterisation of the selective binding of antibiotics vancomycin and teicoplanin by the VanS receptor regulating type A vancomycin resistance in the enterococci. Biochim. Biophys. Acta. 1861, 1951–1959.

Article  CAS  PubMed Central  Google Scholar 

Vimberg V., Cavanagh J.P., Benada O., Kofronova O., Hjerde E., Zieglerova L., Balikova Novotna G. 2018. Teicoplanin resistance in Staphylococcus haemolyticus is associated with mutations in histidine kinases VraS and WalK. Diagn. Microbiol. Infect. Dis. 90, 233–240.

Article  CAS  PubMed  Google Scholar 

Cong Y., Yang S., Rao X. 2020. Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. J. Adv. Res. 21, 169–176.

Article  PubMed  Google Scholar 

Olsufyeva E.N., Tevyashova A.N. 2017. Synthesis, properties, and mechanism of action of new generation of polycyclic glycopeptide antibiotics. Curr. Top. Med. Chem. 17, 2166‒2198.

Article  CAS  PubMed  Google Scholar 

Good V.M., Gwinn M.N., Knowles D.J.C. 1990. MM45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine. J. Antibiotics. 43, 550–555.

Article  CAS  Google Scholar 

Bykov E.E., Mirchink E.P., Isakova E.B., Bychkova E.N., Olsufyeva E.N., Tevyashova A.N. 2017. Study of antibacterial activity and binding energy with the peptide ligand of the hybrid antibiotics vancomycin-azithromycin and eremomycin-azithromycin. Antibiot. Khimioter. 62 (3–4), 10–17.

CAS  Google Scholar 

Olsufyeva E.N., Berdnikova T.F., Miroshnikova O.V., Rerznikova M.I., Preobrazhenskaya M.N. 1999. Chemical modification of antibiotic eremomycin at the asparagin side chain. J. Antibiot. 52, 319–324.

Article  CAS  Google Scholar 

Miroshnikova O.V., Berdnikova T.F., Olsufyeva E.N., Pavlov A.Y., Reznikova M.I., Preobrazhenskaya M.N., Malabarba A., Ciabatti R., Colombo L. 1996. A modification of N-terminal aminoacid in the eremomycin aglycone. J. Antibiot. 49, 1157–1161.

Article  CAS  Google Scholar 

Malabarba A., Ciabatti R., Gerli E., Ferrari P., Colombo L. Ripamonti R., Olsufyeva E.N., Pavlov A.Y., Reznikova M.I., Lazhko E.I., Preobrazhenskaya M.N. 1997. Synthetic glycopeptides. II. Substitution of aminoacides 1 and 3 in teicoplanin aglycon. J. Antibiot. 50, 70–81.

Article  CAS  Google Scholar 

Malabarba A., Ciabatti R., Gerli E., Ferrari P., Colombo L. Ripamonti R., Olsufyeva E.N., Pavlov A.Y., Reznikova M.I., Lazhko E.I., Preobrazhenskaya M.N. 1997. Synthetic glycopeptides. II. Substitution of aminoacides 1 and 3 in teicoplanin aglycon. J. Antibiot. 50, 70–81.

Article  CAS  Google Scholar 

Malabarba A., Ciabatti R., Kettenring J., Ferrari P., Vekey K., Bellagio E, Denaro M. 1996. Structural modification of the active site in teicoplanin and related glycopeptides. Reductive hydrolysis of the 1,2- and 2,3-peptide bonds. J. Org. Chem. 61, 2137–2150.

Article  CAS  Google Scholar 

Okano A., Nakayama A., Wu K., Lindsey E.A., Schammel A.W., Feng Y., Collins K.C., Boger D.L. 2015. Total syntheses and initial evaluation of [Ψ[C(=S)NH]Tpg4]vancomycin, [Ψ[C(=NH)NH]Tpg4]vancomycin, [Ψ[CH2NH]Tpg4]vancomycin and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics. J. Am. Chem. Soc. 137 (10), 3693–3704.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore M.J., Qu S., Tan C., Cai Y., Mogi Y., Keith D.J., Boger D.L. 2020. Next-generation total synthesis of vancomycin. J. Am. Chem. Soc. 142 (37), 16039–16050.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boger D.L., Kim S.H., Miyazaki S., Strittmatter H., Weng J.H., Mori Y., Rogel O., Castle S.L., McAtee J.J. 2000. Total synthesis of the teicoplanin aglycon. J. Am. Chem. Soc. 122, 7416–7417.

Article  CAS  Google Scholar 

Xie J., Okano A., Pierce J.G., James R.C., Stamm S., Crane C.M., Boger D.L. 2012. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J. Am. Chem. Soc. 134, 1284–1297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olsuf'eva E.N., Berdnikova T.F., Dokshina N.Yu., Lomakina N.N., Orlova G.I., Malkova I.V., Prozorova I.N. 1989. Modification of eremomycin by amine groups. Antibiot. Khimioter. 34, 352–358.

CAS  PubMed